Summary Special techniques such as serial macroscopic sectioning (SMS) or immunohistochemical staining (IH) improve the detection rate of micrometastases but this detection is of value only if it improves the prediction of recurrence and survival.
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We first studied the prognosis of 120 patients with a single micrometastasis detected by SMS in a series of 1,680 primary operable breast carcinoma with a median follow-up of 7 years. A significant difference in recurrence (P = 0.005) and in survival (P = 0.0369) was found between node-negative patients and those with one single SMS micrometastasis, but SMS micrometastases were not a predicting factor by multivariate analyses according to the Cox model.
We then studied the prognostic significance of patients with a micrometastasis detected by IH in nodenegative carcinoma: 37 micrometastases from a series of 89 invasive lobular carcinoma (ILC) and 13 single micrometastases from a series of 129 invasive ductal carcinoma (IDC). In the ILC group, IH micrometastases had no prognostic value (median follow-up: 9.3 years). In the IDC group, IH micrometastases were correlated with recurrences (P = 0.01) and were the most significant predicting factor, but were less correlated with survival (median follow-up: 15.6 years).
Three main points emerge from this study: In this study we develop our former results (de Mascarel et al., 1982; Trojani et al., 1987a and (Trojani et al., 1987b (Figure 1 ). This difference was more obvious between nodenegative patients and those with one single macrometastasis (P = 0.0001 for both recurrence and survival). In our study, there was no significant prognostic difference between patients with a single micrometastasis and patients with a single macrometastasis.
Multivariate analyses according to the Cox model were performed with several factors: age, tumour size, grade, lymphatic invasion, presence of micrometastasis or macrometastasis, hormonal receptors and chemotherapy. The most significant factors for recurrence were lymphatic invasion (P= 7 x 10-6), grade (P = 8 x 10-5), tumour size (P = 0.0007) and the presence of one macrometastasis (P = 0.03).
For survival, the most significant factors were grade (P = 9 x 10-6), tumour size (P= 0.00015), negative progesterone receptor (P = 0.0018) and lymphatic invasion (P = 0.016). Micrometastases and the other factors were not significant.
Discussion
Serial sectioning can be performed either on one paraffinembedded block which is serially sectioned at x microns at x levels according to teams (Fisher et al., 1978; Huvos et al., 1971; LBCSG, 1990; Pickren, 1961) , or on a fixed node which is entirely cut into 1 to 1.5 mm slices (de Mascarel, Im 1982; Friedman, 1988 Pickren (1961) , Huvos et al. (1971) and Fisher et al. (1978) failed to find any significant difference in survival between patients whose nodal metastases were occult and those in whom they were absent. On the other hand, the Ludwig group (LBCSG, 1990; LBCSG, 1988; Munro-Neville, 1990) found that there was a definite outcome disadvantage for the 83 patients (9%) who converted to the node-positive classification in 5-year disease-free survival and in overall survival, but no prognostic difference was found between micro-and macrometastases.
By serial macroscopic sectioning Friedman (1988) found that the presence of a clandestine metastasis (small emboli of tumour cells in the sinus margin) in one axillary node produced an increased risk of distant relapse compared to the group with no identified metastases in the axillary lymph node. This risk was identical to that of the group with one parenchymal metastasis and to other combinations of from one to three axillary node metastases. In addition, although the group with only one clandestine metastasis received no locoregional irradiation in contrast to the one parenchymal metastasis and more advanced groups, the rate of local relapse was not significantly increased.
By routine procedures Rosen found an identical prognosis at 10 years for TINIMO patients with a single micro-or macrometastasis, but a poorer one than in negative lymph node patients. On the other hand, for T2NlMO patients, no significant differences were found at 5 or 10 years by comparing the curves for negative lymph node and single micrometastases (Rosen et al., 1989; . Prognostic significant of single metastasis size was also found by Huvos et al. (1971) and Wilkinson et al. (1981) .
Thus, despite the different techniques the prognostic influence of micrometastases has been found by several teams; however, their significance has been variously appreciated vs macrometastasis.
Prognostic value of micrometastases detected by immunohistochemical stainings in standard node-negative carcinoma (IH micrometastases) Materials and methods A first series (Trojani et al., 1987a) (Trojani et al., 1987b There were 11 patients who developed a contralateral breast. Four of these presented recurrences and had to be excluded from the final analysis owing to the impossibility of determining the breast responsible. The number of patients who died from their cancer was eight (9%). Statistical analysis was carried out as previously described.
Results
In the IDC group a significant difference in recurrence (P = 0.01) was found between IH node-negative patients and those with one single IH micrometastasis (Figure 2) . The correlation was not significant for survival (P = 0.07). Multivariate analyses according to the Cox model were performed with several factors in the IDC group: age, tumour size, grade, mitoses, differentiation and lymphatic invasion. For recurrences the presence of micrometastases was the most significant factor (P = 0.011) followed by mitotic index (P = 0.04) and age (P = 0.04). For survival, the presence of micrometastases was also significant (P = 0.027), but less so than mitotic index (P = 0.006) and age (P = 0.011).
In the ILC group no correlation was found between the presence of micrometastases and recurrence or survival rate. 
Discussion
It is not accepted that immunohistochemical stainings increase the rate of detection of micrometastases whatever the histologic type and whatever the methodology used [original HES sections (Byrne et al., 1987; Trojani et al., 1987a,b) or further microscopic sectioning (Bussolati et al., 1986; Cavallere et al., 1989; Noel et al., 1989; Sedmak et al., 1989) . However, the significance of such detected micrometastases still remains a much debated question. Only a few teams have studied the prognostic significance of IH micrometastases (Bussolati et al., 1986; Byrne et al., 1987; Galea et al., 1990; Sedmak et al., 1989; Trojani et al., 1987a,b) . Bussolati et al. (Byrne et al., 1987 ) studied a series of 50 cases of infiltrating lobular carcinoma and found 24% of micrometastases. Despite an insufficient follow-up (3-5 years: range 2 to 7 years), they failed to find any correlation between positive cases and recurrence or survival rates. Byrne et al. (1987) and Galea et al. (1990) did not find any significance of such detected IH micrometastases (respectively four IH micrometastases in 40 N-breast carcinoma with 5 years follow-up and nine IH micrometastases in 98 N-breast carcinoma with 13 years follow-up). On the other hand, Sedmak et al. (1989) in 45 N-breast carcinoma with minimum 10 years follow-up found that the survival curve for patients with IH detected metastases (11%) was significantly worse than that of patients without IH detected metastases (P = 0.0197). Histologic type was not specified in these series.
The present study strengthens our former results in the ILC group in which IH micrometastases had no prognostic value. In the IDC group, IH micrometastases were still correlated with recurrences and were the most significant predicting factor, but were less important for predicting survival.
Conclusion
In conclusion, SMS micrometastases do have a prognostic significance. However, serial macroscopic sectioning does not require excessive work and we continue with it at our institution. On the other hand, it is now well established that IH micrometastases have no prognostic value in infiltrating lobular carcinoma and are of minor interest in the IDC group since they are mainly useful in predicting recurrences. These results are especially important since more cumbersome techniques cannot be used as a routine procedure in many laboratories.
Since the demonstration of axillary lymph node micrometastases has a limited value in predicting survival, the study of new biologic factors in primary tumours must be developed. Several such factors are potential candidates: oncogene products, different kinds of enzymes, hormonal receptor-linked proteins and proliferative index.
